diarrhea from tirzepatide on (Mounjaro) affects approximately 23–31% of patients and is typically mild to moderate, transient, and most common during dose escalation. , It rarely requires discontinuation Common side effects of tirzepatide

Mergers and Acquisitions Our Mergers and Acquisitions (M&A) collection gives you access to the latest insights from Aon's thought leaders to help dealmakers make better decisions

Our dual focus on fat loss and muscle support sets us apart and helps you achieve holistic well-being

Studies link the use of these medications to a significant increase in the risk of gallbladder disease

Our goal is to replace hype with trusted health information so patients can work with their doctors to choose safe, evidence-based therapies. The campaign launched during Obesity Care Week, a global awareness initiative focused on improving access to evidence-based obesity treatment and combating stigma around the disease

No human RCT has confirmed an optimal injectable schedule for cosmetic or wound-healing endpoints